Skip to main content
Susan Hutchinson, MD, Family Medicine, Laguna Hills, CA

SusanLHutchinsonMD

Family Medicine Laguna Hills, CA

Founder of Orange County Migraine & Headache Center

Dr. Hutchinson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hutchinson's full profile

Already have an account?

  • Office

    27151 Green Hills LN
    Laguna Hills, CA 92653
    Phone+1 424-444-7399
    Fax+1 424-253-0814

Education & Training

  • University of California (Irvine)
    University of California (Irvine)Residency, Family Medicine, 1981 - 1985
  • The University of Toledo College of Medicine
    The University of Toledo College of MedicineClass of 1981

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1982 - 2026
  • American Board of Family Medicine Family Medicine

Publications & Presentations

PubMed

Lectures

  • It's Time to Redefine Expectations Around the Acute Treatment of Migraine 
  • Achieving Success In Primary Care: Practical Approaches To Challenging & Complicated Patients - Hilton Head, Sc 
    Destination CME, Hilton Head, South Carolina - 9/12/2013
  • Achieving Success in Primary Care: Practical Approaches to Challenging & Complicated Patients 
    Primary Care Network, Inc., Coeur D Alene, Idaho - 9/5/2013
  • Join now to see all

Press Mentions

  • Birx Notes Harm of Virus Fatigue
    Birx Notes Harm of Virus FatigueAugust 18th, 2020
  • Lilly's OVERCOME Study Reveals Less Than 30 Percent of People Living with Migraine Take Recommended Prescription Medications
    Lilly's OVERCOME Study Reveals Less Than 30 Percent of People Living with Migraine Take Recommended Prescription MedicationsJune 16th, 2020
  • Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial
    Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension TrialJanuary 8th, 2020
  • Join now to see all